CN Patent

CN115417827B — 6-氨基-1,3,5-三嗪类化合物及其合成方法和应用

Assigned to China Pharmaceutical University · Expires 2023-05-26 · 3y expired

What this patent protects

本发明公开了一种6‑氨基‑1，3，5‑三嗪类化合物或其可药用的盐，化合物结构如通式(I)所示。所述化合物对BTK均有较强的抑制作用，同时能够拮抗肿瘤细胞Raji、Ramos增殖，通过选择性与BTK的不可逆结合并抑制其活性，阻断BCR信号通路，对淋巴瘤有较好的抑制作用。

USPTO Abstract

本发明公开了一种6‑氨基‑1，3，5‑三嗪类化合物或其可药用的盐，化合物结构如通式(I)所示。所述化合物对BTK均有较强的抑制作用，同时能够拮抗肿瘤细胞Raji、Ramos增殖，通过选择性与BTK的不可逆结合并抑制其活性，阻断BCR信号通路，对淋巴瘤有较好的抑制作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN115417827B
Jurisdiction
CN
Classification
—
Expires
2023-05-26
Drug substance claim
No
Drug product claim
No
Assignee
China Pharmaceutical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.